Ambryon Biosciences

MyoAAV-3A Serotype

Third myoAAV variant with enhanced cardiac muscle tropism within the muscle-targeted series.

TropismCardiac muscle (enhanced), skeletal muscle, cross-species validated

Characteristics

M-CREATE evolved with cardiac emphasis. Strong cardiomyocyte transduction. Maintained skeletal muscle targeting. Cross-species efficacy demonstrated. Favorable safety profile.

Applications

Cardiac gene therapy. Heart failure treatments. Cardiomyopathies with systemic delivery.

Sequence1 bp

Sign in to view the full sequence.

Sign in

References

  1. 1.Tabebordbar et al. (2021). Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species. Cell — Tabebordbar 2021 MyoAAV

Identifiers & revision